About

The Optic Disc Drusen Studies (ODDS) consortium was established in 2015 as an international alliance of researchers in optic nerve disorders with a special interest in optic disc drusen. Members are from 9 different countries worldwide; the coordination center is in Copenhagen, Denmark.
 
The aim of the consortium is to provide an international forum for optic disc drusen research and clinical topics, where multicenter genotype-phenotype studies and structure-function correlation studies are performed in order to elucidate the mechanisms of optic disc drusen related visual loss.
 

ODDS Consortium members

Steffen Hamann
Chair, MD, PhD, FEBO

Department of Ophthalmology, Rigshospitalet,
University of Copenhagen, Denmark

Clare Fraser
Vice chair, MBBS, MMed, FRANZCO

Save Sight Institute, University of Sydney, Sydney, Australia

 

Lasse Malmqvist
Scientific Secretary, MD, PhD

Department of Ophthalmology, Rigshospitalet,
University of Copenhagen, Denmark

Masoud Aghsaei Fard
MD, FICO

Tehran University of Medical Science, Tehran, Iran

 

Shikha Talwar Bassi
MBBS, DO, DNB, FRCS

Neuroophthalmology services, Sankara Nethralaya, Chennai, India

Shannon Beres
MD

Stanford University Medical Centre, California, USA

 

 

Valérie Biousse
MD

Emory University School of Medicine Atlanta, USA

 

 

 

Lulu Bursztyn
MD, MSc

Ivey Eye Institute, Western University, London, Ontario, Canada

 

 

 

Fiona Costello
MD, FRCPC

Clinical Neurosciences, Calgary, Canada

 

 

 

Alison Crum
MD, PhD

University of Utah, Salt Lake City, Utah, USA

 

 

 

Kathleen B. Digre
MD

University of Utah, Salt Lake City, Utah, USA

 

 

Mays El-Dairi
MD

Duke Eye Center, NC, USA 

 

 

J. Alexander Fraser
MD

Ivey Eye Institute, Western University, London, Ontario, Canada

 

Jesse Gale
MD

Wellington, New Zealand

 

 

Ruth Huna-Baron
MD, PhD

Sheba Medical Center, Tel Hashomer, Israel

 

Bradley Katz
MD, PhD

University of Utah, Salt Lake City, Utah, USA

 

Mitchell Lawlor
MD, PhD

Sydney Eye Hospital, University of Sydney, Australia

Joyce Liao
MD, PhD

Stanford University Medical Centre, California, USA

 

Lea Lykkebirk
MD

Department of Ophthalmology, Rigshospitalet,
University of Copenhagen, Denmark

Peter Maloca
MD

Institute of Molecular and Clinical Ophthalmology (IOB), University of Basel, Switzerland

Heather Moss
MD, PhD

Stanford University Medical Centre, California, USA

 

Nancy J. Newman
MD

Emory University School of Medicine, Atlanta, USA

 

Jason H. Peragallo
MD

Emory University School of Medicine, Atlanta, USA

 

Axel Petzold
MD, PhD

Moorfields Eye Hospital, London, UK

Amsterdam UMC, NL

Nailyn Rasool
MD, FRCPC, FRCSC

UCSF, California, USA

 

 

Amadeo Rodriguez
MD

McMaster University, Hamilton, Ontario, Canada 

 

 

Simon P. Rothenbuehler
MD, FEBO

OCTlab, Department of Ophthalmology, University Hospital Basel, Switzerland

Marie-Bénédicte Rougier
MD

Bordeaux, France 

Patrick A. Sibony
MD

Department of Ophthalmology, State University of New York at Stony Brook, New York, USA

Alvilda Steensberg
MD

Department of Ophthalmology, Rigshospitalet,
University of Copenhagen, Denmark

Prem S. Subramanian
MD, PhD

University of Colorado School of Medicine, Denver, Colorado, USA

Judith Warner
MD, PhD

University of Utah, Salt Lake City, Utah, USA

 

 

Marianne Wegener
MD

Rigshospitalet, University of Copenhagen, Glostrup, Denmark

 

 

Sui H. Wong
MBBS, MD, FRCP, MA

Moorfields Eye Hospital, London, UK

 

 

Geographic location of ODDS consortium members

COLLABORATIONS:

   The vision of ERN–EYE is dedicated to EU patients with rare eye diseases, bringing expertise and knowledge for immediate and future best care.